SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,613,738 | +0.9% | 1,654,470 | +10.0% | 0.34% | +48.2% |
| Q2 2023 | $45,224,368 | -10.0% | 1,504,470 | +8.4% | 0.23% | -30.1% |
| Q1 2023 | $50,266,045 | +38.3% | 1,387,415 | +36.1% | 0.33% | +12.4% |
| Q4 2022 | $36,352,010 | +35.2% | 1,019,120 | +28.3% | 0.29% | +69.6% |
| Q3 2022 | $26,881,000 | +17.0% | 794,120 | 0.0% | 0.17% | +26.7% |
| Q2 2022 | $22,966,000 | -19.1% | 794,120 | -9.5% | 0.14% | +5.5% |
| Q1 2022 | $28,375,000 | +55.0% | 877,945 | +39.8% | 0.13% | +85.5% |
| Q4 2021 | $18,311,000 | – | 627,945 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |